Back

Elevated cystatin C predicts higher mortality in chronic heart failure independently of creatinine clearance based on 24h urine collection

28 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Patricia Lourenco

Sao Joao University Hospital Centre, Porto (Portugal)

31 More presentations in this session

Presentation thumbnail
Professor S. Kim (Seoul, KR)
Abstract
Presentation thumbnail
Mr P. Pliger (Innsbruck, AT)
Abstract
Presentation thumbnail
Professor V. Larina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Associate Professor K. Nochioka (Sendai, JP)
Abstract
Presentation thumbnail
Professor Y. Takeishi (Fukushima, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2018

28 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Cystatin C is better than creatine for prognostic evaluation in heart failure patients
20 May 2023
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
Cystatin C predicts mortality in patients with coronary artery disease both among subjects with and among those without the metabolic syndrome
1 September 2025
thumbnail
Congress Session
Optimising cardiovascular risk prediction and management in patients with renal disease
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources